Spectroscopic analysis of chlamydial major outer membrane protein in support of structure elucidation
Open Access
- 1 November 2018
- journal article
- research article
- Published by Wiley in Protein Science
- Vol. 27 (11) , 1923-1941
Abstract
Chlamydial major outer membrane protein (MOMP) is the major protein constituent of the bacterial pathogen Chlamydia trachomatis. Chlamydia trachomatis Serovars D-K are the leading cause of genital tract infections which can lead to infertility or ectopic pregnancies. A vaccine against Chlamydia is highly desirable but currently not available. MOMP accounts for 60% of the chlamydial protein mass and is considered to be one of the lead vaccine candidates against C. trachomatis. We report on the spectroscopic analysis of C. trachomatis native MOMP Serovars D, E, F, and J as well as C. muridarum MOMP by size exclusion chromatography multi angle light scattering (SEC MALS), circular dichroism (CD) and attenuated total reflectance Fourier transform infrared spectroscopy (ATR-FTIR). MOMP was purified from the native bacterium grown in either adherent HeLa cells or in different suspension cell lines. Our results confirm that MOMP forms homo-trimers in detergent micelles. The secondary structure composition of C. trachomatis MOMP was conserved across serovars, but different from composition of C. muridarum MOMP with a 13% (CD) to 18% (ATR-FTIR) reduction in -sheet conformation for C. trachomatis MOMP. When Serovar E MOMP was isolated from suspension cell lines the -helix content increased by 7% (CD) to 13% (ATIR-FTIR). Maintenance of a native-like tertiary and quaternary structure in subunit vaccines is important for the generation of protective antibodies. This biophysical characterization of MOMP presented here serves, in the absence of functional assays, as a method for monitoring the structural integrity of MOMP.Keywords
This publication has 65 references indexed in Scilit:
- Formulation, characterization, and expression of a recombinant MOMP Chlamydia trachomatis DNA vaccine encapsulated in chitosan nanoparticlesInternational Journal of Nanomedicine, 2013
- A Novel Transport Mechanism for MOMP in Chlamydophila pneumoniae and Its Putative Role in Immune-TherapyPLOS ONE, 2013
- Quantitative proteomics reveals metabolic and pathogenic properties of Chlamydia trachomatis developmental formsMolecular Microbiology, 2011
- Amphipols stabilize the Chlamydia major outer membrane protein and enhance its protective ability as a vaccineVaccine, 2011
- TP0326, a Treponema pallidum β‐barrel assembly machinery A (BamA) orthologue and rare outer membrane proteinMolecular Microbiology, 2011
- Identification of Immunodominant Antigens by Probing a WholeChlamydia trachomatisOpen Reading Frame Proteome Microarray Using Sera from Immunized MiceInfection and Immunity, 2011
- Genome Sequencing of Recent Clinical Chlamydia trachomatis Strains Identifies Loci Associated with Tissue Tropism and Regions of Apparent RecombinationInfection and Immunity, 2010
- Identification of immunodominant antigens of Chlamydia trachomatis using proteome microarraysVaccine, 2010
- Biophysical and Stabilization Studies of the Chlamydia trachomatis Mouse Pneumonitis Major Outer Membrane ProteinMolecular Pharmaceutics, 2009
- Using circular dichroism collected as a function of temperature to determine the thermodynamics of protein unfolding and binding interactionsNature Protocols, 2006